Hepatitis C Information - Clinical Trial: Long-term Peginterferon alpha-2a Plus Ribavirin to

Clinical Trial: Long-term Peginterferon alpha-2a Plus Ribavirin to
Long-term Peginterferon alpha-2a Plus Ribavirin to Treat Chronic Hepatitis C in HIV-Infected Patients This study is currently recruiting patients. Verified by National Institutes of Health Clinical

Hepatitis Central, Chronic Hepatitis Symptoms
Pruritis and the hepatitis C virus. Pruritis in chronic hepatitis C (Itching) Ascites, Symptoms, Signs, and Diagnosis table Of Contents Information at this website is for

Chronic Hepatitis: Hepatitis: Merck Manual Home Edition
others, the disease gradually worsens. Over a period of years, about 20% of people with chronic hepatitis C and about 50% of people with autoimmune hepatitis develop cirrhosis, with or without liver

Methadone Usage Associated with Lower Rate of Chronic Hepatitis C
Stated in the opposite way, methadone users were significantly less likely to have chronic hepatitis C (79%) than non-methadone users (91%). Also, the researchers reported that methadone users with

IDEAL Study - Hepatitis c Clinical Study for patients with chronic hep
MAJOR CLINICAL STUDY FOR PATIENTS WITH CHRONIC HEPATITIS C Understanding the IDEAL Study An overview of the study. Frequently Asked Questions Answers to your common questions. Who May Participate View